Transparency in COVID-19 vaccine development, purchase & distribution
This procedure concerns transparency measures related to the development, purchase, and distribution of COVID-19 vaccines within the European Union. It aims to ensure public trust and accountability in the process.
It affects citizens by providing clarity on how vaccines were procured and distributed, and impacts pharmaceutical companies involved in vaccine production and supply chains.
Documents
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
position · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
report · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
proposal · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
report · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
proposal · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
motion · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
motion · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
report · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
report · EN · 2026-05-04
EU-Transparency in the COVID-19 vaccine development, purchase and distribution
motion · EN · 2026-05-04